Gilead's experimental remdesivir has emerged as the most promising candidate against the deadly new coronavirus. But some unexpected confusion has cropped up about its China patent—the latest being a Chinese firm claiming it's successfully copied the drug and started mass production.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,